Filing Details
- Accession Number:
- 0000885590-10-000063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-02 21:35:43
- Reporting Period:
- 2010-12-01
- Filing Date:
- 2010-12-02
- Accepted Time:
- 2010-12-02 21:35:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1453140 | Rajiv Silva De | C/O 7150 Mississauga Road Mississauga A6 L5N 8M5 | President & Coo Spec. Pharma. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Acquisiton | 2010-12-01 | 18,277 | $8.11 | 511,691 | No | 4 | M | Direct | |
| Common Shares, No Par Value | Disposition | 2010-12-01 | 18,277 | $27.00 | 493,414 | No | 4 | S | Direct | |
| Common Shares, No Par Value | Disposition | 2010-12-01 | 201,620 | $27.00 | 291,794 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Non-Qualified Stock Options (right to purchase) | Disposition | 2010-12-01 | 18,277 | $0.00 | 18,277 | $8.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 208,743 | 2010-01-05 | 2019-01-05 | No | 4 | M | Direct |
Footnotes
- Stock Options were exercised and underlying Common Stock sold pursuant to a 10b5-1 Selling Plan adopted by the Reporting Person on August 8, 2010.
- Restricted Share Units were sold pursuant to a 10b5-1 Selling Plan adopted by the Reporting Person on June 29, 2009.
Billionaire Hedge Funds
